433 related articles for article (PubMed ID: 27221314)
21. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
22. Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.
Sah SK; Park KH; Yun CO; Kang KS; Kim TY
Antioxid Redox Signal; 2016 Feb; 24(5):233-48. PubMed ID: 26462411
[TBL] [Abstract][Full Text] [Related]
23. Differential Involvement of Programmed Cell Death Ligands in Skin Immune Responses.
Tanaka R; Ichimura Y; Kubota N; Saito A; Nakamura Y; Ishitsuka Y; Watanabe R; Fujisawa Y; Mizuno S; Takahashi S; Fujimoto M; Okiyama N
J Invest Dermatol; 2022 Jan; 142(1):145-154.e8. PubMed ID: 34310947
[TBL] [Abstract][Full Text] [Related]
24. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
[TBL] [Abstract][Full Text] [Related]
25. IMQ Induced K14-VEGF Mouse: A Stable and Long-Term Mouse Model of Psoriasis-Like Inflammation.
Wang X; Sun J; Hu J
PLoS One; 2015; 10(12):e0145498. PubMed ID: 26691862
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
[TBL] [Abstract][Full Text] [Related]
27. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model.
Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC
Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324
[TBL] [Abstract][Full Text] [Related]
28. Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation.
Sun Y; Zhang J; Huo R; Zhai T; Li H; Wu P; Zhu X; Zhou Z; Shen B; Li N
Int Immunopharmacol; 2015 Feb; 24(2):392-399. PubMed ID: 25576402
[TBL] [Abstract][Full Text] [Related]
29. Cytokine network in psoriasis revisited.
Michalak-Stoma A; Pietrzak A; Szepietowski JC; Zalewska-Janowska A; Paszkowski T; Chodorowska G
Eur Cytokine Netw; 2011 Dec; 22(4):160-8. PubMed ID: 22236965
[TBL] [Abstract][Full Text] [Related]
30. Oral Administration of Vanillin Improves Imiquimod-Induced Psoriatic Skin Inflammation in Mice.
Cheng HM; Chen FY; Li CC; Lo HY; Liao YF; Ho TY; Hsiang CY
J Agric Food Chem; 2017 Nov; 65(47):10233-10242. PubMed ID: 29073354
[TBL] [Abstract][Full Text] [Related]
31. Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation.
Jiang Y; Wang W; Zheng X; Jin H
J Immunol Res; 2020; 2020():5980190. PubMed ID: 32280718
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory Effect of Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Histamine H4 Receptor Agonist 4-Methylhistamine.
Kim CH; Lee JM; Yoo JK; Kim JS; Kim SU; Chang KT; Choo YK
Scand J Immunol; 2016 Jun; 83(6):409-17. PubMed ID: 26900758
[TBL] [Abstract][Full Text] [Related]
33. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.
Yoshiki R; Kabashima K; Honda T; Nakamizo S; Sawada Y; Sugita K; Yoshioka H; Ohmori S; Malissen B; Tokura Y; Nakamura M
J Invest Dermatol; 2014 Jul; 134(7):1912-1921. PubMed ID: 24569709
[TBL] [Abstract][Full Text] [Related]
34. Gomisin M2 alleviates psoriasis‑like skin inflammation by inhibiting inflammatory signaling pathways.
Kim N; Lee S; Kang J; Kwon TK; Khang D; Kim SH
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34664681
[TBL] [Abstract][Full Text] [Related]
35. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
Morimura S; Oka T; Sugaya M; Sato S
J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
[TBL] [Abstract][Full Text] [Related]
36. IL-36α is involved in hapten-specific T-cell induction, but not local inflammation, during contact hypersensitivity.
Numata T; Yoshizaki T; Yamaguchi S; Shimura E; Iwakura Y; Harada K; Sudo K; Tsuboi R; Nakae S
Biochem Biophys Res Commun; 2018 Nov; 506(3):429-436. PubMed ID: 30352688
[TBL] [Abstract][Full Text] [Related]
37. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice.
Zhang S; Liu X; Mei L; Wang H; Fang F
BMC Complement Altern Med; 2016 Aug; 16(1):334. PubMed ID: 27581210
[TBL] [Abstract][Full Text] [Related]
38. Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation.
Pohin M; Guesdon W; Mekouo AA; Rabeony H; Paris I; Atanassov H; Favot L; Mcheik J; Bernard FX; Richards CD; Amiaud J; Blanchard F; Lecron JC; Morel F; Jégou JF
Eur J Immunol; 2016 Jul; 46(7):1737-51. PubMed ID: 27122058
[TBL] [Abstract][Full Text] [Related]
39. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin.
Correa da Rosa J; Malajian D; Shemer A; Rozenblit M; Dhingra N; Czarnowicki T; Khattri S; Ungar B; Finney R; Xu H; Zheng X; Estrada YD; Peng X; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Mar; 135(3):712-20. PubMed ID: 25583101
[TBL] [Abstract][Full Text] [Related]
40. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L
Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
